Distribution and retention of the antitumor agent 195mPt-cis-dichlorodiammine platinum (II) in man
- PMID: 4823268
Distribution and retention of the antitumor agent 195mPt-cis-dichlorodiammine platinum (II) in man
Similar articles
-
In vivo distribution studies of radioactively labelled platinum complexes; cis-dichlorodiammine platinum(II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum(IV), cis-dichloro-bis-cyclopropylamine platinum(II), and cis-diammine 1,1-cyclobutanedicarboxylate platinum(II) in patients with malignant disease, using a gamma camera.Cancer Chemother Pharmacol. 1985;14(3):253-7. doi: 10.1007/BF00258128. Cancer Chemother Pharmacol. 1985. PMID: 3888431
-
Biochemical pharmacology of homologous alicyclic mixed amine platinum(II) complexes in sensitive and resistant tumor cell lines.Cancer Res. 1994 Jul 1;54(13):3468-73. Cancer Res. 1994. PMID: 8012968
-
Organo-platinum complexes as antitumor agents (review).Anticancer Res. 1982 May-Jun;2(3):173-86. Anticancer Res. 1982. PMID: 6751211 Review.
-
cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.Clin Cancer Res. 1997 Nov;3(11):2063-74. Clin Cancer Res. 1997. PMID: 9815598
-
A comparative study of the distribution in the male rat of platinum-labelled cis-dichlorodiammine platinum (II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum (I), and cis-dichloro-bis-cyclopropylamine platinum (II).Cancer Chemother Pharmacol. 1983;10(2):90-5. doi: 10.1007/BF00446216. Cancer Chemother Pharmacol. 1983. PMID: 6682017 No abstract available.
Cited by
-
Alterations in plasma pharmacokinetics of cisplatin in tumor-bearing rats.Cancer Chemother Pharmacol. 1988;22(1):1-4. doi: 10.1007/BF00254171. Cancer Chemother Pharmacol. 1988. PMID: 3396142
-
In vivo distribution studies of radioactively labelled platinum complexes; cis-dichlorodiammine platinum(II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum(IV), cis-dichloro-bis-cyclopropylamine platinum(II), and cis-diammine 1,1-cyclobutanedicarboxylate platinum(II) in patients with malignant disease, using a gamma camera.Cancer Chemother Pharmacol. 1985;14(3):253-7. doi: 10.1007/BF00258128. Cancer Chemother Pharmacol. 1985. PMID: 3888431
-
Pharmacokinetics of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum IV (CHIP) in patients with advanced cancer.Cancer Chemother Pharmacol. 1983;11(1):23-8. doi: 10.1007/BF00257411. Cancer Chemother Pharmacol. 1983. PMID: 6883623
-
Preclinical imaging characteristics and quantification of Platinum-195m SPECT.Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1347-1354. doi: 10.1007/s00259-017-3643-2. Epub 2017 Feb 11. Eur J Nucl Med Mol Imaging. 2017. PMID: 28190123
-
Renal failure and platinum pharmacokinetics in three patients treated with cis-diamminedichloroplatinum(II) and whole-body hyperthermia.Cancer Chemother Pharmacol. 1983;11(3):162-6. doi: 10.1007/BF00254197. Cancer Chemother Pharmacol. 1983. PMID: 6685578
MeSH terms
Substances
LinkOut - more resources
Full Text Sources